Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour

John F Peden1, Martin Farrall

  • 1Department of Cardiovascular Medicine, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK.

Human Molecular Genetics
|August 31, 2011
PubMed

Insights

Genetic studies have identified 34 common variants associated with coronary artery disease (CAD), a leading global cause of death. Further research is needed to understand the mechanisms behind these genetic links and discover more CAD-related genes.

Area of Science:

  • Genetics
  • Cardiovascular Disease Research
  • Genomics

Background:

  • Coronary artery disease (CAD) is the primary cause of mortality globally.
  • Familial clustering of CAD suggests a significant genetic component.
  • Previous genome-wide association studies (GWAS) have identified numerous common variants linked to CAD.

Purpose of the Study:

  • To summarize the current understanding of genetic loci associated with coronary artery disease.
  • To highlight the implications of identified variants for disease pathogenesis and risk factor mechanisms.
  • To identify future research directions for uncovering novel CAD-related genes.

Main Methods:

  • Large-scale genome-wide and gene-centric genotyping studies.
  • Analysis of tens of thousands of cases and controls.
  • Examination of allelic heterogeneity and copy number variation in common variants.
  • Utilizing quantitative trait loci associations and Mendelian randomization studies.

Main Results:

  • 34 distinct genetic loci associated with common coronary artery disease variants have been mapped.
  • Some identified loci contain candidate genes suggesting conventional or emerging risk factor pathways.
  • Common variants explain approximately 4% of inter-individual CAD risk variation and up to 13% of heritability.
  • Mechanistic links for most loci remain uncertain, indicating potential for novel research avenues.

Conclusions:

  • Genetic factors play a substantial role in coronary artery disease susceptibility.
  • Current common variants explain a small proportion of CAD heritability, suggesting many genes remain undiscovered.
  • Future large-scale GWAS and resequencing studies are expected to identify additional common and rare variants contributing to CAD risk.

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...